Eidos Therapeutics has just one experimental drug in a rare, fatal genetic disease, but it has moved the drug into the clinic quickly.

Topics:  eidos therapeutics   rare   disease   drug   
BING NEWS:
  • Binghamton University joins groundbreaking $42.8 million inflammatory disease treatment project
    Binghamton University will play a key role in a federal grant of up to $42.8 million to develop an implantable device that acts as a living pharmacy to treat inflammatory diseases.
    11/5/2024 - 6:04 am | View Link
  • Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug
    Ascendis Pharma and Novo Nordisk sign exclusive global license for TransCon technology, aiming to advance obesity, type 2 diabetes, and cardiovascular treatments.
    11/4/2024 - 4:34 am | View Link
  • Worcester startup raises $45M for ALS and schizophrenia treatment
    Leal Therapeutics has secured yet another multi-million financing deal as the Worcester-based biotechnology startup has raised $45 million to advance its therapeutics for individuals with central ...
    11/1/2024 - 4:41 am | View Link
  • Tempus exec-founded biotech startup raises $62 million
    The fundraise for Pathos AI, established by Eric Lefkofsky and Ryan Fukushima, pushes its valuation to $600 million.
    10/30/2024 - 4:38 am | View Link
  • Chicago biotech startup Pathos AI raises $62 million to fuel new drug development
    Biotech startup Pathos AI has pulled in one of the largest funding rounds for a Chicago company so far this year. Here's how much, and what they'll use it for.
    10/29/2024 - 8:14 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News